• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定RORγ作为结肠癌的一个良好生物标志物。

Identification of RORγ as a favorable biomarker for colon cancer.

作者信息

Pan Xiaofei, Li Bao, Zhang Gan, Gong Yuyong, Liu Rui, Chen Benxin, Li Yang

机构信息

Department of Colorectal and Anal Surgery, the Affiliated Hospital of West Anhui Health Vocational College, Lu'an, China.

Department of Burns and Orthopedic Surgery, the Affiliated Hospital of West Anhui Health Vocational College, Lu'an, China.

出版信息

J Int Med Res. 2021 May;49(5):3000605211008338. doi: 10.1177/03000605211008338.

DOI:10.1177/03000605211008338
PMID:33947261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113924/
Abstract

OBJECTIVE

To evaluate the expression of retinoid-related orphan receptor gamma (RORγ) and its potential role in the prognosis of colon cancer.

METHODS

The Cancer Genome Atlas and GSE117606 were used to evaluate to RORγ levels in colon cancer, and real-time quantitative polymerase chain reaction was applied for validation. UALCAN and MEXPRESS were used to analyze the associations of RORγ expression with clinical parameters. The survival analysis was conducted in GEPIA.

RESULTS

RORγ expression was significantly lower in colon tumors than in adjacent normal mucosa tissues. RORγ expression was significantly associated with tumor stage, lymph node metastasis, and liver metastasis. The area under the curve for diagnosis was 0.71. Decreased RORγ expression was positively correlated with the incidence of lymphatic invasion, microsatellite instability, the presence of residual tumor, venous invasion, and copy number variation. Overall survival was longer in patients with higher RORγ expression, especially those with microsatellite instability-high features. Methylation analysis revealed that hypermethylation of the RORγ promoter was associated with the colon cancer stage.

CONCLUSIONS

RORγ downregulation could be a potential biomarker for colon cancer, especially for predicting prognosis. Decreased RORγ expression in colon tumor may be associated with promoter hypermethylation.

摘要

目的

评估维甲酸相关孤儿受体γ(RORγ)的表达及其在结肠癌预后中的潜在作用。

方法

利用癌症基因组图谱和GSE117606评估结肠癌中RORγ水平,并应用实时定量聚合酶链反应进行验证。使用UALCAN和MEXPRESS分析RORγ表达与临床参数的相关性。在GEPIA中进行生存分析。

结果

结肠癌组织中RORγ表达显著低于相邻正常黏膜组织。RORγ表达与肿瘤分期、淋巴结转移和肝转移显著相关。诊断曲线下面积为0.71。RORγ表达降低与淋巴浸润、微卫星不稳定性、残留肿瘤、静脉浸润和拷贝数变异的发生率呈正相关。RORγ表达较高的患者总生存期较长,尤其是具有微卫星高度不稳定特征的患者。甲基化分析显示,RORγ启动子的高甲基化与结肠癌分期相关。

结论

RORγ下调可能是结肠癌的潜在生物标志物,尤其是用于预测预后。结肠癌中RORγ表达降低可能与启动子高甲基化有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/c02dae41ca14/10.1177_03000605211008338-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/438848942b17/10.1177_03000605211008338-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/2f68fe2073b6/10.1177_03000605211008338-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/99c6f22d0114/10.1177_03000605211008338-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/3c820c666563/10.1177_03000605211008338-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/398656f9e905/10.1177_03000605211008338-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/b8f28a7c101c/10.1177_03000605211008338-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/c02dae41ca14/10.1177_03000605211008338-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/438848942b17/10.1177_03000605211008338-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/2f68fe2073b6/10.1177_03000605211008338-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/99c6f22d0114/10.1177_03000605211008338-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/3c820c666563/10.1177_03000605211008338-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/398656f9e905/10.1177_03000605211008338-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/b8f28a7c101c/10.1177_03000605211008338-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785f/8113924/c02dae41ca14/10.1177_03000605211008338-fig7.jpg

相似文献

1
Identification of RORγ as a favorable biomarker for colon cancer.鉴定RORγ作为结肠癌的一个良好生物标志物。
J Int Med Res. 2021 May;49(5):3000605211008338. doi: 10.1177/03000605211008338.
2
RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.结直肠癌中 RUNX3 启动子甲基化:与微卫星不稳定性的关系及其作为新型血清肿瘤标志物的适用性。
Anticancer Res. 2010 Jul;30(7):2673-82.
3
Low microsatellite instability is associated with poor prognosis in stage C colon cancer.微卫星低度不稳定与C期结肠癌的不良预后相关。
J Clin Oncol. 2005 Apr 1;23(10):2318-24. doi: 10.1200/JCO.2005.00.109.
4
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.微卫星不稳定散发性结肠癌中RUNX3的表观遗传失活
Int J Cancer. 2004 Dec 10;112(5):754-9. doi: 10.1002/ijc.20472.
5
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.微卫星不稳定的结肠癌中hMLH1启动子的高甲基化
Cancer Res. 1998 Aug 1;58(15):3455-60.
6
Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.启动子高甲基化频率和BRAF突变可区分遗传性非息肉病性结直肠癌与散发性微卫星高度不稳定(MSI-H)结直肠癌。
Fam Cancer. 2004;3(2):101-7. doi: 10.1023/B:FAME.0000039861.30651.c8.
7
Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.启动子超甲基化使肿瘤抑制因子 FAM134B 失活,并与结直肠癌的不良预后相关。
Genes Chromosomes Cancer. 2018 May;57(5):240-251. doi: 10.1002/gcc.22525. Epub 2018 Jan 30.
8
CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype.结肠癌中CHFR启动子高甲基化与微卫星不稳定性表型相关。
Carcinogenesis. 2005 Jun;26(6):1152-6. doi: 10.1093/carcin/bgi058. Epub 2005 Mar 10.
9
Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.DCC/18q和ERBB2/17q的拷贝数变异与微卫星稳定型结肠癌的无病生存期相关。
Int J Cancer. 2017 Apr 1;140(7):1653-1661. doi: 10.1002/ijc.30584.
10
The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.Claudin-11 启动子高甲基化在喉鳞状细胞癌中的临床意义。
Med Sci Monit. 2017 Jul 26;23:3635-3640. doi: 10.12659/msm.904751.

引用本文的文献

1
Discovery and pharmacological characterization of 1,2,3,4-tetrahydroquinoline derivatives as RORγ inverse agonists against prostate cancer.发现并药理学表征 1,2,3,4-四氢喹啉衍生物作为 RORγ 反向激动剂用于治疗前列腺癌。
Acta Pharmacol Sin. 2024 Sep;45(9):1964-1977. doi: 10.1038/s41401-024-01274-z. Epub 2024 May 2.
2
Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms.揭示二硫化物诱导细胞焦亡相关长链非编码RNA在结肠癌中的作用:免疫治疗反应、化疗敏感性的预后指标及对细胞死亡机制的见解
Front Mol Biosci. 2023 Oct 17;10:1254232. doi: 10.3389/fmolb.2023.1254232. eCollection 2023.
3

本文引用的文献

1
APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.APEX1 是一种新型的肝细胞癌诊断和预后生物标志物。
Aging (Albany NY). 2020 Mar 13;12(5):4573-4591. doi: 10.18632/aging.102913.
2
Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases.肿瘤位置对中国东部地区结直肠癌患者临床病理及分子标志物的影响:2356例病例分析
Front Genet. 2020 Feb 25;11:96. doi: 10.3389/fgene.2020.00096. eCollection 2020.
3
Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer.
Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn colorectal cancer cells from modifying their O-glycosylation status.
人脐带来源间充质干细胞和人胎盘来源间充质干细胞的侧群细胞能够抑制 Tn 结直肠癌细胞的恶性行为,改变其 O-糖基化状态。
Stem Cell Res Ther. 2023 May 26;14(1):145. doi: 10.1186/s13287-023-03334-3.
胶原激酶受体作为转移性结肠癌潜在的治疗靶点
Front Oncol. 2020 Feb 12;10:125. doi: 10.3389/fonc.2020.00125. eCollection 2020.
4
Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance.MUC5AC-CD44 轴在结直肠癌进展和化疗耐药中的分子意义。
Mol Cancer. 2020 Feb 25;19(1):37. doi: 10.1186/s12943-020-01156-y.
5
Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor.结直肠癌中 DNA 甲基化与基因表达的相互作用,一种追踪这种肿瘤的潜在血浆生物标志物。
Sci Rep. 2020 Feb 18;10(1):2813. doi: 10.1038/s41598-020-59690-0.
6
Thirty-Day Morbidity after Simultaneous Resection of Colorectal Cancer and Colorectal Liver Metastasis: American College of Surgeons NSQIP Analysis.结直肠癌和结直肠肝转移同时切除术后 30 天发病率:美国外科医师学院 NSQIP 分析。
J Am Coll Surg. 2020 Apr;230(4):617-627.e9. doi: 10.1016/j.jamcollsurg.2019.12.018. Epub 2020 Jan 30.
7
Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells.新型纳米载体提高抗癌药物 Auraptene 对结肠癌细胞的递送效率。
Sci Rep. 2020 Jan 31;10(1):1606. doi: 10.1038/s41598-020-58527-0.
8
Microsatellite instability in Costa Rican patients with colorectal adenocarcinoma and its association with overall survival and response to fluoropyrimidine-based chemotherapy.哥斯达黎加结直肠癌患者微卫星不稳定性及其与总生存期和氟嘧啶类化疗反应的关系。
Cancer Epidemiol. 2020 Apr;65:101680. doi: 10.1016/j.canep.2020.101680. Epub 2020 Jan 24.
9
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
10
Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter.阿司匹林通过消除 NF-κB 与 COX-2 启动子的结合来增强结肠癌细胞对顺铂的敏感性。
Aging (Albany NY). 2020 Jan 6;12(1):611-627. doi: 10.18632/aging.102644.